Clinical and Health System Determinants of Venous Thromboembolism Event Rates After Hip Arthroplasty: An International Comparison

for the International Methodology Consortium for Coded Health Information (IMECCHI

Research output: Contribution to journalArticle

Abstract

Background: Routinely collected hospital data provide increasing opportunities to assess the performance of health care systems. Several factors may, however, influence performance measures and their interpretation between countries. Objective: We compared the occurrence of in-hospital venous thromboembolism (VTE) in patients undergoing hip replacement across 5 countries and explored factors that could explain differences across these countries. Methods: We performed cross-sectional studies independently in 5 countries: Canada; France; New Zealand; the state of California; and Switzerland. We first calculated the proportion of hospital inpatients with at least one deep vein thrombosis (DVT) or pulmonary embolism by using numerator codes from the corresponding Patient Safety Indicator. We then compared estimates from each country against a reference value (benchmark) that displayed the baseline risk of VTE in such patients. Finally, we explored length of stay, number of secondary diagnoses coded, and systematic use of ultrasound to detect DVT as potential factors that could explain between-country differences. Results: The rates of VTE were 0.16% in Canada, 1.41% in France, 0.84% in New Zealand, 0.66% in California, and 0.37% in Switzerland, while the benchmark was 0.58% (95% confidence interval, 0.35–0.81). Factors that could partially explain differences in VTE rates between countries were hospital length of stay, number of secondary diagnoses coded, and proportion of patients who received lower limb ultrasound to screen for DVT systematically before hospital discharge. An exploration of the French data showed that the systematic use of ultrasound may be associated with over detection of DVT but not pulmonary embolism. Conclusions: In-hospital VTE rates after arthroplasty vary widely across countries, and a combination of clinical, data-related, and health system factors explain some of the variations in VTE rates across countries.

Original languageEnglish (US)
JournalMedical Care
DOIs
StateAccepted/In press - Jul 11 2018

Fingerprint

Venous Thromboembolism
Arthroplasty
Hip
Venous Thrombosis
Health
Benchmarking
Length of Stay
Switzerland
Pulmonary Embolism
New Zealand
France
Canada
Patient Safety
Inpatients
Lower Extremity
Reference Values
Cross-Sectional Studies
Confidence Intervals
Delivery of Health Care

Keywords

  • benchmarking
  • health services research
  • international classification of diseases
  • international comparisons
  • outcomes assessment
  • Patient Safety Indicator

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Clinical and Health System Determinants of Venous Thromboembolism Event Rates After Hip Arthroplasty : An International Comparison. / for the International Methodology Consortium for Coded Health Information (IMECCHI.

In: Medical Care, 11.07.2018.

Research output: Contribution to journalArticle

for the International Methodology Consortium for Coded Health Information (IMECCHI. / Clinical and Health System Determinants of Venous Thromboembolism Event Rates After Hip Arthroplasty : An International Comparison. In: Medical Care. 2018.
@article{47b95f4505874d918093a4739d6ba490,
title = "Clinical and Health System Determinants of Venous Thromboembolism Event Rates After Hip Arthroplasty: An International Comparison",
abstract = "Background: Routinely collected hospital data provide increasing opportunities to assess the performance of health care systems. Several factors may, however, influence performance measures and their interpretation between countries. Objective: We compared the occurrence of in-hospital venous thromboembolism (VTE) in patients undergoing hip replacement across 5 countries and explored factors that could explain differences across these countries. Methods: We performed cross-sectional studies independently in 5 countries: Canada; France; New Zealand; the state of California; and Switzerland. We first calculated the proportion of hospital inpatients with at least one deep vein thrombosis (DVT) or pulmonary embolism by using numerator codes from the corresponding Patient Safety Indicator. We then compared estimates from each country against a reference value (benchmark) that displayed the baseline risk of VTE in such patients. Finally, we explored length of stay, number of secondary diagnoses coded, and systematic use of ultrasound to detect DVT as potential factors that could explain between-country differences. Results: The rates of VTE were 0.16{\%} in Canada, 1.41{\%} in France, 0.84{\%} in New Zealand, 0.66{\%} in California, and 0.37{\%} in Switzerland, while the benchmark was 0.58{\%} (95{\%} confidence interval, 0.35–0.81). Factors that could partially explain differences in VTE rates between countries were hospital length of stay, number of secondary diagnoses coded, and proportion of patients who received lower limb ultrasound to screen for DVT systematically before hospital discharge. An exploration of the French data showed that the systematic use of ultrasound may be associated with over detection of DVT but not pulmonary embolism. Conclusions: In-hospital VTE rates after arthroplasty vary widely across countries, and a combination of clinical, data-related, and health system factors explain some of the variations in VTE rates across countries.",
keywords = "benchmarking, health services research, international classification of diseases, international comparisons, outcomes assessment, Patient Safety Indicator",
author = "{for the International Methodology Consortium for Coded Health Information (IMECCHI} and Januel, {Jean Marie} and Romano, {Patrick S} and Couris, {Chantal M.} and Phil Hider and Hude Quan and Cyrille Colin and Bernard Burnand and Ghali, {William A.}",
year = "2018",
month = "7",
day = "11",
doi = "10.1097/MLR.0000000000000959",
language = "English (US)",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Clinical and Health System Determinants of Venous Thromboembolism Event Rates After Hip Arthroplasty

T2 - An International Comparison

AU - for the International Methodology Consortium for Coded Health Information (IMECCHI

AU - Januel, Jean Marie

AU - Romano, Patrick S

AU - Couris, Chantal M.

AU - Hider, Phil

AU - Quan, Hude

AU - Colin, Cyrille

AU - Burnand, Bernard

AU - Ghali, William A.

PY - 2018/7/11

Y1 - 2018/7/11

N2 - Background: Routinely collected hospital data provide increasing opportunities to assess the performance of health care systems. Several factors may, however, influence performance measures and their interpretation between countries. Objective: We compared the occurrence of in-hospital venous thromboembolism (VTE) in patients undergoing hip replacement across 5 countries and explored factors that could explain differences across these countries. Methods: We performed cross-sectional studies independently in 5 countries: Canada; France; New Zealand; the state of California; and Switzerland. We first calculated the proportion of hospital inpatients with at least one deep vein thrombosis (DVT) or pulmonary embolism by using numerator codes from the corresponding Patient Safety Indicator. We then compared estimates from each country against a reference value (benchmark) that displayed the baseline risk of VTE in such patients. Finally, we explored length of stay, number of secondary diagnoses coded, and systematic use of ultrasound to detect DVT as potential factors that could explain between-country differences. Results: The rates of VTE were 0.16% in Canada, 1.41% in France, 0.84% in New Zealand, 0.66% in California, and 0.37% in Switzerland, while the benchmark was 0.58% (95% confidence interval, 0.35–0.81). Factors that could partially explain differences in VTE rates between countries were hospital length of stay, number of secondary diagnoses coded, and proportion of patients who received lower limb ultrasound to screen for DVT systematically before hospital discharge. An exploration of the French data showed that the systematic use of ultrasound may be associated with over detection of DVT but not pulmonary embolism. Conclusions: In-hospital VTE rates after arthroplasty vary widely across countries, and a combination of clinical, data-related, and health system factors explain some of the variations in VTE rates across countries.

AB - Background: Routinely collected hospital data provide increasing opportunities to assess the performance of health care systems. Several factors may, however, influence performance measures and their interpretation between countries. Objective: We compared the occurrence of in-hospital venous thromboembolism (VTE) in patients undergoing hip replacement across 5 countries and explored factors that could explain differences across these countries. Methods: We performed cross-sectional studies independently in 5 countries: Canada; France; New Zealand; the state of California; and Switzerland. We first calculated the proportion of hospital inpatients with at least one deep vein thrombosis (DVT) or pulmonary embolism by using numerator codes from the corresponding Patient Safety Indicator. We then compared estimates from each country against a reference value (benchmark) that displayed the baseline risk of VTE in such patients. Finally, we explored length of stay, number of secondary diagnoses coded, and systematic use of ultrasound to detect DVT as potential factors that could explain between-country differences. Results: The rates of VTE were 0.16% in Canada, 1.41% in France, 0.84% in New Zealand, 0.66% in California, and 0.37% in Switzerland, while the benchmark was 0.58% (95% confidence interval, 0.35–0.81). Factors that could partially explain differences in VTE rates between countries were hospital length of stay, number of secondary diagnoses coded, and proportion of patients who received lower limb ultrasound to screen for DVT systematically before hospital discharge. An exploration of the French data showed that the systematic use of ultrasound may be associated with over detection of DVT but not pulmonary embolism. Conclusions: In-hospital VTE rates after arthroplasty vary widely across countries, and a combination of clinical, data-related, and health system factors explain some of the variations in VTE rates across countries.

KW - benchmarking

KW - health services research

KW - international classification of diseases

KW - international comparisons

KW - outcomes assessment

KW - Patient Safety Indicator

UR - http://www.scopus.com/inward/record.url?scp=85049908664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049908664&partnerID=8YFLogxK

U2 - 10.1097/MLR.0000000000000959

DO - 10.1097/MLR.0000000000000959

M3 - Article

C2 - 30001253

AN - SCOPUS:85049908664

JO - Medical Care

JF - Medical Care

SN - 0025-7079

ER -